21,200 Shares in Corteva, Inc. $CTVA Bought by iSAM Funds UK Ltd

iSAM Funds UK Ltd acquired a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 21,200 shares of the company’s stock, valued at approximately $1,795,000. Corteva makes up approximately 1.3% of iSAM Funds UK Ltd’s investment portfolio, making the stock its 10th biggest holding.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. William B. Walkup & Associates Inc. boosted its holdings in shares of Corteva by 2.9% in the 1st quarter. William B. Walkup & Associates Inc. now owns 4,457 shares of the company’s stock valued at $373,000 after buying an additional 126 shares in the last quarter. Wilkerson Advisory Group LLC raised its stake in shares of Corteva by 6.7% during the 1st quarter. Wilkerson Advisory Group LLC now owns 2,112 shares of the company’s stock worth $177,000 after acquiring an additional 133 shares in the last quarter. AdvisorNet Financial Inc lifted its position in Corteva by 2.4% during the first quarter. AdvisorNet Financial Inc now owns 5,694 shares of the company’s stock valued at $477,000 after acquiring an additional 135 shares during the last quarter. First Horizon Corp boosted its stake in Corteva by 9.2% in the first quarter. First Horizon Corp now owns 1,600 shares of the company’s stock valued at $134,000 after acquiring an additional 135 shares in the last quarter. Finally, Aviance Capital Partners LLC grew its holdings in Corteva by 1.3% in the first quarter. Aviance Capital Partners LLC now owns 11,008 shares of the company’s stock worth $922,000 after purchasing an additional 137 shares during the last quarter. Hedge funds and other institutional investors own 81.54% of the company’s stock.

Corteva Trading Up 2.7%

Corteva stock opened at $90.07 on Thursday. The stock has a 50-day moving average price of $83.17 and a 200 day moving average price of $80.86. The company has a market capitalization of $60.09 billion, a price-to-earnings ratio of 59.65, a price-to-earnings-growth ratio of 2.69 and a beta of 0.57. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $90.97. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.24 by $0.06. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. Corteva’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same period last year, the firm posted $2.20 EPS. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Sell-side analysts anticipate that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be given a $0.18 dividend. This represents a $0.72 annualized dividend and a yield of 0.8%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio is currently 47.68%.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on the company. Oppenheimer upped their price target on Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research report on Thursday, July 23rd. Jefferies Financial Group boosted their target price on Corteva from $95.00 to $97.00 in a research note on Thursday, May 7th. Morgan Stanley upped their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $101.00 price target on shares of Corteva in a research note on Monday, August 3rd. Finally, Barclays raised their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Fourteen analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $91.50.

Corteva Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.